Proudly Part of Jefferson Health
Multicenter, Double-Blind Placebo-Controlled, Study of Vonapanitase (PRT-201) Administered Immediately after Radiocephalic Arteriovenous Fistula Creation in Patients with Chronic Kidney Disease
test